サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428442

糖尿病管理における人工知能の世界市場レポート 2024年

Artificial Intelligence in Diabetes Management Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
糖尿病管理における人工知能の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

糖尿病管理における人工知能市場規模は、今後数年間で急激に成長すると予想されています。 2028年には31.7%の年間複合成長率（CAGR）で18億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、AIを活用した意思決定支援システムの実装、遠隔医療との統合、ゲノムデータの利用、糖尿病管理における人工知能に対する規制のサポートに起因すると考えられます。この期間中に予想される主要動向には、ウェアラブル技術の進歩、個別化された治療計画の開発、継続的な血糖値モニタリングの進歩、AIを活用したリスク予測、行動変容のサポートなどが含まれます。

予測される糖尿病症例の急増により、糖尿病管理市場における人工知能の導入が促進されることになります。血糖値の上昇を特徴とする糖尿病は、目の問題、心臓発作や脳卒中などの心臓血管の問題、腎臓の病気などのさまざまな合併症を引き起こします。人工知能は、糖尿病患者の変動する血糖値に関する洞察を提供し、これまで利用されていなかったデータを活用することにより、糖尿病管理において極めて重要な役割を果たしています。たとえば、2021年 12月に米国の政府間組織である国際糖尿病連盟が報告したように、世界の成人（20～79歳）の糖尿病人口は5億3,700万人であり、2030年までに6億4,300万人に増加すると予測されています。このように、糖尿病の有病率の増加により、糖尿病管理における人工知能実践の統合が促進されています。

遠隔医療サービスに対する需要が高まっているため、糖尿病管理分野での人工知能の導入が促進される展望です。遠隔医療には、遠隔通信とデジタルツールを活用して、患者と医療提供者に遠隔医療サービスを提供することが含まれます。遠隔医療サービスにおける糖尿病ケアに人工知能を融合することで、パーソナライゼーション、モニタリング機能、全体的な効率が強化されます。この統合により、合併症の早期発見が促進され、服薬アドヒアランスが促進され、意思決定のサポートが強化されるため、患者の転帰が向上し、医療リソースが最適化されます。たとえば、2023年 4月、米国の非営利団体であるFAIR Health Inc.は、全国的な遠隔医療の利用が7.3%急増し、2022年 12月の医療請求明細の5.5%から2023年 1月には5.9%に上昇したと報告しました。遠隔医療サービスに対する需要の高まりにより、糖尿病管理における人工知能の進歩が推進されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 糖尿病管理における人工知能市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の糖尿病管理における人工知能市場規模実績と成長、2018～2023年
  • 世界の糖尿病管理における人工知能市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の糖尿病管理における人工知能市場、装置別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 診断装置
  • 血糖値監視装置
  • インスリン投与装置
  • その他
  • 世界の糖尿病管理における人工知能市場、技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 事例ベースの推論
  • インテリジェントデータ分析
  • 世界の糖尿病管理における人工知能市場、最終用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • クリニック
  • 在宅医療
  • 研究機関

第7章 地域と国の分析

  • 世界の糖尿病管理における人工知能市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の糖尿病管理における人工知能市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 世界の糖尿病管理における人工知能市場の競合情勢
  • 世界の糖尿病管理における人工知能市場の企業プロファイル
    • Alphabet Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Medtronic Plc
    • Dexcom Inc.

第31章 その他の大手と革新的な企業

  • Insulet Corporation
  • Tandem Diabetes Care Inc.
  • LifePlus Inc.
  • Livongo Health Inc.
  • Xeris Pharmaceuticals Inc.
  • Virta Health Corp.
  • Informed Data Systems Inc.
  • Bigfoot Biomedical Inc.
  • Lark Technologies Inc.
  • Smart Meter LLC
  • Diabeloop SA
  • Quin Technology Ltd.
  • Wellthy Therapeutics Pvt Ltd.
  • Admetsys LLC
  • DreaMed Diabetes Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r14287

Artificial intelligence in diabetes management involves the use of AI technologies and algorithms to analyze patterns in behavior that may lead to fluctuations in blood sugar levels, whether it be hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar), in patients with diabetes. The application of artificial intelligence in diabetes management contributes to improvements in various aspects of diabetes care, including decision support, prediction of blood sugar levels, lifestyle guidance, and treatment management.

The primary devices integrated into artificial intelligence in diabetes management include diagnostic devices, glucose monitoring devices, insulin delivery devices, and others. Diagnostic devices play a crucial role in determining the nature or underlying cause of specific phenomena, particularly those associated with health issues such as diabetes. The various techniques employed in this context include case-based reasoning and intelligent data analysis. These technologies find application in diverse settings, including hospitals, clinics, home care settings, and research institutes.

The artificial intelligence in diabetes management market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in diabetes management market statistics, including the artificial intelligence in diabetes management industry's global market size, regional shares, competitors with artificial intelligence in diabetes management market share, detailed artificial intelligence in diabetes management market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in diabetes management industry. This artificial intelligence in diabetes management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.48 billion in 2023 to $0.63 billion in 2024 at a compound annual growth rate (CAGR) of 31.6%. The growth observed in the historical period can be attributed to the accumulation of data, the increasing prevalence of diabetes cases, pressures on healthcare costs, and the early applications of artificial intelligence in diabetes management.

The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 31.7%. The anticipated growth in the forecast period can be attributed to the implementation of AI-powered decision support systems, integration with telemedicine, utilization of genomic data, and regulatory support for artificial intelligence in diabetes management. Key trends expected during this period encompass advancements in wearable technology, the development of personalized treatment plans, continuous glucose monitoring advances, AI-powered risk prediction, and support for behavioral modification.

The anticipated surge in diabetes cases is set to drive the adoption of artificial intelligence within the diabetes management market. Diabetes, characterized by elevated blood glucose levels, leads to various complications such as eye issues, cardiovascular problems such as heart attacks and strokes, kidney ailments, among others. Artificial intelligence plays a pivotal role in diabetes management by furnishing insights into diabetic patients' fluctuating blood sugar levels and harnessing previously untapped data. For instance, in December 2021, as reported by the International Diabetes Federation, an intergovernmental organization in the US, the global diabetic population among adults (20-79 years old) stood at 537 million and is forecasted to escalate to 643 million by 2030 and 783 million by 2045. Thus, the mounting prevalence of diabetes is fueling the integration of artificial intelligence in diabetes management practices.

The escalating demand for telehealth services is poised to bolster the adoption of artificial intelligence within the diabetes management domain. Telehealth involves leveraging telecommunications and digital tools to deliver remote healthcare services to patients and healthcare providers. The amalgamation of artificial intelligence into diabetes care within telehealth services amplifies personalization, monitoring capabilities, and overall efficiency. This integration aids in early complication detection, promotes medication adherence, and provides enhanced decision-making support, thereby elevating patient outcomes and optimizing healthcare resources. For instance, in April 2023, FAIR Health Inc., a non-profit organization in the US, reported a 7.3% surge in national telehealth usage, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the escalating demand for telehealth services is propelling the advancement of artificial intelligence in the realm of diabetes management.

Advancements in technology stand out as a prominent trend gaining traction within the artificial intelligence segment of the diabetes management market. Key players in this domain are dedicated to pioneering cutting-edge technological solutions to fortify their market presence. For instance, in October 2022, Dr. Mohan's Diabetes Specialties Center, an India-based chain of hospitals specializing in diabetes care, introduced a groundbreaking artificial intelligence-driven platform for precision diabetes care known as the 3D Initiative. The initiative comprises three components such as DIA, an AI-powered chatbot facilitating pre-recorded digital interactions; DIALA, a user-friendly smartphone application tailored for patients; and DIANA, a medical app focusing on precise diabetic care. Backed by an advanced Total Experience (TX) Automation Platform, this innovation powers an AI-enabled virtual assistant engaging with patients across platforms such as Facebook Messenger, WhatsApp, Google Business Message, and the web.

Significant players in the artificial intelligence sphere of diabetes management are actively developing novel products such as wearable devices aimed at monitoring glucose levels to gain a competitive edge in the market. Wearable glucose monitoring devices are compact, often technologically advanced gadgets designed to continuously or intermittently measure and monitor blood glucose levels. For instance, in October 2023, Dexcom Inc., a US-based medical device manufacturing company, introduced the next-generation G7 continuous glucose monitoring (CGM) system. This system caters to all diabetics nationwide, including pregnant individuals and those aged two years or older. The Dexcom CGM device ensures enhanced user safety by providing alerts for severe hypoglycemia up to 20 minutes in advance, thereby reducing uncertainty in diabetes management. Moreover, the system simplifies sensor replacement with a 12-hour grace period, and its remote monitoring feature facilitates the exchange of glucose data with up to 10 followers.

In January 2022, Glooko Inc., a leading US-based digital diabetes and chronic condition management company, successfully acquired Xbird for an undisclosed amount. Through this acquisition, Xbird is set to play a crucial role in Glooko's strategic vision for leveraging artificial intelligence and providing tailored digital coaching for individuals dealing with chronic diseases. The integration of xbird's innovative Just in Time Adaptive Intervention (JITAI) capabilities with Glooko's well-established global presence is expected to enhance patient outcomes. Xbird GmbH, the acquired company, is based in Germany and specializes in AI-enabled diabetes management.

Major companies operating in the artificial intelligence in diabetes management market report are Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.

North America was the largest region in the artificial intelligence (AI) in diabetes management market in 2023. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in diabetes management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence in diabetes management market consists of revenues earned by entities by providing automated retinal screening, clinical decision support, disease prediction, and treatment management. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in the diabetes management market also includes sales of glucose monitors, support vector machines, and smart wearables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence in Diabetes Management Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in diabetes management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in diabetes management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in diabetes management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Device: Diagnostic Devices; Glucose Monitoring Devices; Insulin Delivery Devices; Other Devices
  • 2) By Techniques: Case-Based Reasoning; Intelligent Data Analysis
  • 3) By End-Use: Hospitals; Clinics; Home Care Settings; Research Institutes
  • Companies Mentioned: Alphabet Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Medtronic Plc; Dexcom Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence in Diabetes Management Market Characteristics

3. Artificial Intelligence in Diabetes Management Market Trends And Strategies

4. Artificial Intelligence in Diabetes Management Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Intelligence in Diabetes Management Market Size and Growth

  • 5.1. Global Artificial Intelligence in Diabetes Management Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Intelligence in Diabetes Management Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Intelligence in Diabetes Management Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Intelligence in Diabetes Management Market Segmentation

  • 6.1. Global Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic Devices
  • Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Other Devices
  • 6.2. Global Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Case-Based Reasoning
  • Intelligent Data Analysis
  • 6.3. Global Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Care Settings
  • Research Institutes

7. Artificial Intelligence in Diabetes Management Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence in Diabetes Management Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Intelligence in Diabetes Management Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Intelligence in Diabetes Management Market

  • 8.1. Asia-Pacific Artificial Intelligence in Diabetes Management Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Intelligence in Diabetes Management Market

  • 9.1. China Artificial Intelligence in Diabetes Management Market Overview
  • 9.2. China Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Intelligence in Diabetes Management Market

  • 10.1. India Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Intelligence in Diabetes Management Market

  • 11.1. Japan Artificial Intelligence in Diabetes Management Market Overview
  • 11.2. Japan Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Intelligence in Diabetes Management Market

  • 12.1. Australia Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Intelligence in Diabetes Management Market

  • 13.1. Indonesia Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Intelligence in Diabetes Management Market

  • 14.1. South Korea Artificial Intelligence in Diabetes Management Market Overview
  • 14.2. South Korea Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Intelligence in Diabetes Management Market

  • 15.1. Western Europe Artificial Intelligence in Diabetes Management Market Overview
  • 15.2. Western Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Intelligence in Diabetes Management Market

  • 16.1. UK Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Intelligence in Diabetes Management Market

  • 17.1. Germany Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Intelligence in Diabetes Management Market

  • 18.1. France Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Intelligence in Diabetes Management Market

  • 19.1. Italy Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Intelligence in Diabetes Management Market

  • 20.1. Spain Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Intelligence in Diabetes Management Market

  • 21.1. Eastern Europe Artificial Intelligence in Diabetes Management Market Overview
  • 21.2. Eastern Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Intelligence in Diabetes Management Market

  • 22.1. Russia Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Intelligence in Diabetes Management Market

  • 23.1. North America Artificial Intelligence in Diabetes Management Market Overview
  • 23.2. North America Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Intelligence in Diabetes Management Market

  • 24.1. USA Artificial Intelligence in Diabetes Management Market Overview
  • 24.2. USA Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Intelligence in Diabetes Management Market

  • 25.1. Canada Artificial Intelligence in Diabetes Management Market Overview
  • 25.2. Canada Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Intelligence in Diabetes Management Market

  • 26.1. South America Artificial Intelligence in Diabetes Management Market Overview
  • 26.2. South America Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Intelligence in Diabetes Management Market

  • 27.1. Brazil Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Intelligence in Diabetes Management Market

  • 28.1. Middle East Artificial Intelligence in Diabetes Management Market Overview
  • 28.2. Middle East Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Intelligence in Diabetes Management Market

  • 29.1. Africa Artificial Intelligence in Diabetes Management Market Overview
  • 29.2. Africa Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Intelligence in Diabetes Management Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence in Diabetes Management Market Competitive Landscape
  • 30.2. Artificial Intelligence in Diabetes Management Market Company Profiles
    • 30.2.1. Alphabet Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic Plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Dexcom Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Intelligence in Diabetes Management Market Other Major And Innovative Companies

  • 31.1. Insulet Corporation
  • 31.2. Tandem Diabetes Care Inc.
  • 31.3. LifePlus Inc.
  • 31.4. Livongo Health Inc.
  • 31.5. Xeris Pharmaceuticals Inc.
  • 31.6. Virta Health Corp.
  • 31.7. Informed Data Systems Inc.
  • 31.8. Bigfoot Biomedical Inc.
  • 31.9. Lark Technologies Inc.
  • 31.10. Smart Meter LLC
  • 31.11. Diabeloop SA
  • 31.12. Quin Technology Ltd.
  • 31.13. Wellthy Therapeutics Pvt Ltd.
  • 31.14. Admetsys LLC
  • 31.15. DreaMed Diabetes Ltd.

32. Global Artificial Intelligence in Diabetes Management Market Competitive Benchmarking

33. Global Artificial Intelligence in Diabetes Management Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence in Diabetes Management Market

35. Artificial Intelligence in Diabetes Management Market Future Outlook and Potential Analysis

  • 35.1 Artificial Intelligence in Diabetes Management Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence in Diabetes Management Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence in Diabetes Management Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer